XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue - Summary of Revenue by Sales Category (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Information [Line Items]    
Net sales $ 9,964 $ 9,747
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 9,961 9,744
Other    
Segment Reporting Information [Line Items]    
Net sales 3 3
U.S.    
Segment Reporting Information [Line Items]    
Net sales 3,846 3,928
U.S. | Other    
Segment Reporting Information [Line Items]    
Net sales 3 3
Int’l    
Segment Reporting Information [Line Items]    
Net sales 6,118 5,819
Int’l | Other    
Segment Reporting Information [Line Items]    
Net sales 0 0
Established Pharmaceutical Products | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,226 1,189
Established Pharmaceutical Products | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 0 0
Established Pharmaceutical Products | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,226 1,189
Nutritionals | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,068 1,967
Nutritionals | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 878 812
Nutritionals | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,190 1,155
Diagnostics | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,214 2,688
Diagnostics | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 931 1,335
Diagnostics | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,283 1,353
Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 4,453 3,900
Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,034 1,778
Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,419 2,122
Key Emerging Markets | Established Pharmaceutical Products | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 928 912
Key Emerging Markets | Established Pharmaceutical Products | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 0 0
Key Emerging Markets | Established Pharmaceutical Products | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 928 912
Other | Established Pharmaceutical Products | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 298 277
Other | Established Pharmaceutical Products | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 0 0
Other | Established Pharmaceutical Products | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 298 277
Pediatric Nutritionals | Nutritionals | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,009 924
Pediatric Nutritionals | Nutritionals | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 514 459
Pediatric Nutritionals | Nutritionals | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 495 465
Adult Nutritionals | Nutritionals | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,059 1,043
Adult Nutritionals | Nutritionals | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 364 353
Adult Nutritionals | Nutritionals | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 695 690
Core Laboratory | Diagnostics | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,205 1,182
Core Laboratory | Diagnostics | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 310 289
Core Laboratory | Diagnostics | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 895 893
Molecular | Diagnostics | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 129 147
Molecular | Diagnostics | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 42 47
Molecular | Diagnostics | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 87 100
Point of Care | Diagnostics | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 139 134
Point of Care | Diagnostics | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 98 93
Point of Care | Diagnostics | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 41 41
Rapid Diagnostics | Diagnostics | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 741 1,225
Rapid Diagnostics | Diagnostics | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 481 906
Rapid Diagnostics | Diagnostics | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 260 319
Rhythm Management | Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 562 527
Rhythm Management | Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 271 260
Rhythm Management | Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 291 267
Electrophysiology | Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 587 505
Electrophysiology | Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 269 238
Electrophysiology | Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 318 267
Heart Failure | Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 305 281
Heart Failure | Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 237 218
Heart Failure | Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 68 63
Vascular | Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 689 617
Vascular | Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 254 218
Vascular | Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 435 399
Structural Heart | Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 515 461
Structural Heart | Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 233 210
Structural Heart | Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 282 251
Neuromodulation | Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 226 196
Neuromodulation | Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 181 155
Neuromodulation | Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 45 41
Diabetes Care | Medical Devices | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 1,569 1,313
Diabetes Care | Medical Devices | U.S. | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 589 479
Diabetes Care | Medical Devices | Int’l | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales $ 980 $ 834